Innovating the Next Generation of Biologics
Scientific Innovation with a Patient-Centric Vision
Zyconix Biologics is an innovation-driven pharmaceutical research company specializing in novel formulation development of biologics, Antibody -Drug Conjugates (ADCs), Monoclonal Antibodies (mAbs), Fusion Proteins, Glycoproteins, Recombinant Hormones, Peptibodies, Peptides, Cell & Gene Therapy (CGT) and expertise in the Drug Device Combination Product (DDCP) development and regulatory filling.
Zyconix has collaborate with pharmaceutical and biotechnology companies to transform complex biologics into stable, manufacturable, and patient-centric products.
Learn More About Us
Comprehensive Development Solutions
Applying expert formulation science across the full biologics pipeline — from molecule selection through commercial readiness.
Novel Biologics Formulation Development
Antibody - DrugConjugates(ADCs), Biosimilars, Monoclonal antibodies(mAbs), Fusion proteins, Glycoproteins, Recombinant hormones, Peptibodies, Peptides, and Cell&genetherapy(CGT).
Drug-Device Combination Products
Device selection, development and preparation of Design History File (DHF). Documentation for Drug Device Combination product like Prefilled syringes with safety device, Autoinjectors and Pen Injectors, Wearable Device, Microneedle systems, and Other patient -focused delivery platforms.
Advanced Drug Delivery Technologies
Exploration of innovative approaches including long-acting injectables, sustained-release systems, topical biologics, nanoparticle-based delivery, and other emerging technologies.
Analytical Characterisation
Development and application of analytical methods to assess product quality, stability, aggregation, degradation, and overall formulation performance along with drug-device combination products.
Driving Innovation Through Advanced Technologies
We leverage cutting-edge platform technologies to develop next-generation biologics formulations — from high-concentration injectables and lyophilised systems to complex drug-device combination products and stability-enhanced biologics.
Explore TechnologiesSupporting Diverse Therapeutic Areas
Our scientific capabilities support formulation and development programmes across multiple therapeutic areas.
From Scientific Concept to Clinical Translation
Every development programme follows a structured, science-driven workflow designed to improve efficiency while maintaining quality throughout product development.
A Collaborative Scientific Partner
We work closely with our clients to solve formulation and delivery challenges through practical scientific solutions.
Our approach is built on:
- Innovation-driven research
- Science-based decision making
- Quality by Design (QbD) principles
- Focus on manufacturability
Advancing Knowledge Through Research
We regularly publish technical articles and scientific insights covering biologics formulation, ADC development, drug-device combinations, biosimilars, long-acting injectables, and emerging delivery technologies.
Stay connected with the latest developments shaping the future of biologic medicines.
Read Our Insights
Let's Build the Next Generation of Biologics Together
Whether you are developing a first-in-class biologic, improving an existing therapeutic, or exploring innovative drug delivery technologies, Zyconix Biologics is ready to support your scientific journey.
We welcome collaboration with biotechnology companies, pharmaceutical organisations, academic institutions, medical device innovators, and strategic research partners.